Company Filing History:
Years Active: 2010-2013
Title: Yasunobu Kano: Innovator in Biotechnology
Introduction
Yasunobu Kano is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for protein expression and vaccine technology. With a total of 3 patents, his work has the potential to impact various applications in medicine and microbiology.
Latest Patents
One of Kano's latest patents involves a gene expressing a bifidobacterium surface-presented fusion protein. This invention provides a means of expressing and displaying a protein on the cell surface of bifidobacteria. The gene for expressing this protein is designed to link a gene coding for a substrate-binding membrane protein with a gene coding for the target protein or peptide. This innovation allows transformed bifidobacteria to express the target protein or peptide on their surface, making it useful as an oral vaccine when the target is an antigen protein or peptide.
Another notable patent from Kano is a shuttle vector for a microorganism of the genus Bifidobacterium. This vector has a wide host range and a large copy number, enabling high expression of desired proteins. The invention includes an expression vector capable of expressing a desired gene in bifidobacteria, as well as transformed bifidobacteria and an antitumor agent comprising the bifidobacteria as an active ingredient.
Career Highlights
Throughout his career, Yasunobu Kano has worked with several notable companies, including Anaeropharma Science, Inc. and Morishita Jintan Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and innovation.
Collaborations
Kano has collaborated with esteemed colleagues such as Minoru Fujimori and Shun'ichiro Taniguchi. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Yasunobu Kano is a distinguished inventor whose work in biotechnology has led to significant advancements in protein expression and vaccine development. His innovative patents reflect his commitment to improving health outcomes through scientific research.